unexpected allergic drug reaction), many serious errors are preventable (Tables 1 and 2)*. 2,3 Medication safety uses best practices and technology to avert PADEs.
In the medication use process, the nurse at the bedside is the most vulnerable. Leape et al., in a 1995 study showed that 38% of medication errors causing PADEs occurred during administration, and only 2% of these administration errors were intercepted. 4 In general, 51% of all non-intercepted potential ADEs and PADEs occurred during the administration stage. 4 Errors vs. harm -While it is important to work to reduce the frequency of all medication errors, the first priority must be preventing errors with the greatest potential for harm, that is, those involving high-risk medications. 5, 6 Only a few oral medications are high-risk drugs, while a great number of IV medications pose a high risk of harm (e.g., heparin, insulin, morphine and propofol.) [7] [8] [9] IV medications have been associated with 54% of potential ADEs, 10 56% of medication errors, 11 almost 61% of the most serious and life-threatening errors (Bates DW, personal communication 2001) , and often result in the most serious outcomes of medication errors. 12 A nurse would never give one hundred pills to a patient; however, he or she can all too easily program a general-purpose infusion device to deliver a comparatively massive overdose (Table 3) . 5 In addition to the tragic results for the patient and family, an infusion related PADE can be a careerending mistake for the nurse and result in lost productivity for associated staff.
"The cost of medication errors goes beyond the direct costs such as legal settlements and loss of reputation. In seeking to improve medication safety, the goal is to change the system, make it easier to do the right thing, prevent individuals from committing errors, and build high-reliability organizations. To achieve this goal, the use of technology is essential. 13 However, until recently, no technology has been able to safeguard against the type of medication errors most likely to cause harm -intravenous (IV) infusion delivery of high-alert medications. 13, 14 New safety software with error-prevention, data-collection and networking capabilities (see Appendix) specifically targets high-risk infusion medication errors. A so-called "smart pump" (computerized infusion device) is a standalone infusion pump supported by dose error reduction software. A smart medication safety system is a more advanced technology that provides capabilities beyond those of smart pumps, as discussed in the Appendix.
"The health care change that we've lived through in the past five years is going to be a constant state, resulting from the expectations of the patient and clinicians need for innovative, quality health care. 2 • Adverse drug reaction (ADR) fatalities are the 7th leading cause of death in Canada, after cancer, heart disease, stroke, pulmonary disease and accidents, using 1995 Statistics Canada data.
• ADRs prolong Canadian hospital stay by an average of 4.6 days, costing Canada $300 million annually.
• One-third of adverse drug reaction deaths are preventable.
• Between 1999 and 2003, the rate of adverse ADRs for teaching and community hospitals increased from 12% to 22% Reduced risk -Prior to implementation of the safety system, a large community hospital conducted a failure mode and effects analysis (FMEA) to determine a risk priority score related to setting IV heparin infusion rates. At that time, without a reliable mode of error detection for drug infusions, the score was 210. Following implementation of a safety system and software, the score dropped from 210 to 56 -nearly a four-fold reduction in risk. 6 An IV Medication Harm Index has been developed to allow hospitals to quantify averted harm achieved by using advanced technology.
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Actionable data provide basis for best practice improvements -CQI reports provide:
• accurate information about clinical care
• time, date and care areas where most Guardrails Together, we are making health care better.
For example, time-based data revealed that during the first six months of a smart IV system being used in a pediatric hospital, infusion programming errors peaked at 10 am, 7 pm, 10 pm and midnight ( Figure  4 , darkened area). Analysis showed that these were especially busy times, when shift change, high admission volumes and activities such as drug distribution combined to distract nurses. As a result of these findings, the units were closed during shift change, and the timing of several elective activities was changed to reduce distractions. Since these changes, pump alerts are much less frequent and all of the former error peaks have been eliminated (Figure 4 , lighter area). 18 This example shows how smart IV alerts can be the "canary in the mine" 19 to identify where nursing workload issues exist and to target quality improvement efforts to improve patient safety, best practices and nursing satisfaction. 20 These figures include costs related to extended patient stays, but do not include the costs of injuries to patients, malpractice costs, cost of admissions due to ADEs, or litigation. The cost per PADE inflated to 2004 dollars is US$6,500. 18 A three-year study completed at a major medical centre showed that the average incremental expense was approximately US$8,000 per PADE.
Improved safety culture -
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Margins and working capital -Such costs become even more important in light of recent trends in hospital total margins and working capital. While small hospitals tend to fare better than community or teaching hospitals, total margins for all hospitals decreased between 1997 and 2002 and are now only about 1%. 21 Working capital shows a similar downward trend, with a negative percentage for all hospitals for the first time in 2002. 21 Thus, any patient safety initiative, including the use of medication safety technology, must be evaluated in terms of not only clinical benefits, but also financial and operational improvements. 16 of stay. A recent study of the Alaris ® System identified a statistically significant reduction in length of stay in the participating ICU.
Length of stay -
22
Additional benefits -In addition, improving patient safety by averting the highest-risk-of-harm medication errors can improve quality of care and patient throughput. Greater efficiency can help improve a hospital's efficiency rating. Moreover, averting medication errors can also avoid the lost staff productivity associated with PADEs. A single user interface for multiple types of devices simplifies training. CQI data can be used to identify opportunities to reduce drug costs (e.g., by avoiding propofol overdosing in the sedation of ventilated patients).
23 Finally, the cost to upgrade from a "smart pump" (computerized infusion device) to a smart medication safety system can be higher than the cost to implement a smart system initially.
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ROI -
In an average 350-bed hospital, the typical time for payback after implementation ranges from 15 to 20 months, based upon the cost of PADEs.
Nationwide averages for a 350-bed hospital are 368 PADEs/year and $6,000 to $8,000 per PADE, compared with a $1.6 to $2.0 million investment in a complete system. 15 PADE costs do not include negative public relations, litigation costs or insurance costs.
Public relations/fundraising, balanced scorecardDocumented improvements in medication safetythat is, averted errors -make a good story to take to the community for a balanced scorecard and for fundraising. Consumers can readily understand the need to avert infusion programming "typos" that can lead to significant overdoses and appreciate the benefits of having a computerized "brain at the bedside" to double-check programming accuracy.
"You can leverage investments into more fundraising. The more you do as a health care organization to provide better and safer care for your community, the more your community will support your fundraising efforts. So, there are opportunities to feature things such as the Alaris ® System to help with fundraising." Dr. James MacLean, President and CEO Markham Stouffville Hospital
Partnering for performance
Improving best practices throughout the hospital requires that a company and a hospital become performance partners to go beyond the point-of-care "test of reasonableness" to be able to act on the data. Examples of hospital partnering include productive collaboration to:
• establish medication limits for different care areas • analyze data (e.g., correlate medication delivery alerts with shift, time of day and day of the week)
• help hospitals comply with regulatory mandates
• create new educational and safety campaigns focused on best practice changes Hospitals have indicated that they want to know that the company's goals align with their goals. They want a partner that will work together with them to customize the safety software, train staff and install the systems quickly and without disruption according to timelines that a hospital can rely upon.
Following installation, the hospital and supplier continue to work together to improve the system and infusion therapy best practices, to help with the production and analysis of measurable and actionable data, and help to communicate benefits that can be shared with the community for public relations and fundraising efforts.
Purchasing options -Purchasing the systems using a proof-of-concept model allows a hospital to forego payment on the software and the implementation services for three to six months following implementation, when the system's benefit to the hospital has been shown.
Strategic decision -Conference particip nts viewed purchase of a safety system and software as both an operational and a strategic decision. Infusion pumps need to be replaced on a regular basis. Those monies can be allocated to purchase of the IV medication safety system as the best investment for clinical, 
Conclusion
The creation of the institution-specific software data set, as well as the flexibility, effectiveness and auto-matic data gathering capabilities of available safety systems, allow a hospital to meet all four goals listed in the Canadian Adverse Events Study as leadership requirements for efforts to make patient care safer:
• encourage the reporting of AEs -the system automatically documents averted errors
• continued monitoring of the incidence of these events -CQI logs provide data to document decreased incidence
• judicious application of new technologies -safety systems with the safety software provide exceptional "speed to impact" in averting the most critical medication errors The Alaris ® System with the Guardrails ® Suite of safety software A smar t IV medication safety system -• Integrated medication safety platform that offers dose error reduction safety software across all infusions on one platform and includes PCA, large volume delivery, patient monitoring and syringe delivery
• Integrates patient monitoring using a common user and IT networked interface
• Provides comprehensive CQI reporting and analytic tools that allow hospitals to more frequently improve best practices
• Speed to impac t through CQI reporting and analytic tools that are networked, providing immediate access to the data and accelerating best practice and process improvements
• Networked for Safety and Workflow Efficiency-providing a single gateway into hospital systems from multiple modalities.
Dose error reduction software -The Alaris ® System with the Guardrails ® Suite of safety software incorporates dose error reduction software (DERS) that enables a hospital to incorporate their best-practice rules, including dosing limits, into the system to perform a final "test of reasonableness" at the point of care. This computerized IV medication safety system with both error-prevention and data-collection capabilities comprises a new technology that allows hospitals to specifically target high-risk infusion medication errors.
Averting high-risk medication errors -When infusion programming exceeds best-practice limits, the safety software provides an alert when the "start" key is pressed. Infusion cannot begin until the alert is addressed.
Programming steps that previously would have led to a medication error are brought to a nurse's awareness and corrected as they occur, thereby improving patient safety and reducing the potential for harm.
Patient care area customization -The safety software allows an institution to create specific "profiles" with drug libraries and other parameters customized for different patient care areas or patient types: e.g., adult critical care, oncology, adult medical/surgical, obstetrics, pediatrics, etc. Clinical advisories can be included in the software to help ensure that clinicians use best practices.
